InvestorsHub Logo
Followers 48
Posts 5862
Boards Moderated 0
Alias Born 06/03/2010

Re: None

Wednesday, 08/16/2017 9:16:14 AM

Wednesday, August 16, 2017 9:16:14 AM

Post# of 2537
News out:

"Vectura Group plc announces that following successful completion of the feasibility work it has signed an exclusive global agreement with Dynavax Technologies Corporation (DVAX) for the clinical application of Vectura's proprietary smart nebuliser technology to deliver Dynavax's investigational immunotherapeutic agent to lung cancer patients (VR347). The agreement covers the Phase I and Phase II development programmes and Vectura will provide devices and device related support to Dynavax which is responsible for the rest of the programme."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DVAX News